Theregen Overview
- Year Founded
-
2003
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Theregen General Information
Description
Developer of cell-based therapies designed to address cardiovascular diseases. The company's epicardial patch Anginera induces formation of mature blood vessels in the human myocardium, enabling physicians to address ischemia and induce arteriogenesis in patients.
Contact Information
Website
www.theregen.comCorporate Office
- 225 Bush Street
- Floor 16
- San Francisco, CA 94104
- United States
Corporate Office
- 225 Bush Street
- Floor 16
- San Francisco, CA 94104
- United States
Theregen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Dec-2016 | Completed | Out of Business | |||
| 3. Early Stage VC | 07-Feb-2006 | Completed | Startup | |||
| 2. Early Stage VC (Series A1) | 17-Jan-2006 | $1.5M | $3.27M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 08-Nov-2005 | $1.77M | $1.77M | Completed | Startup |
Theregen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
Theregen Patents
Theregen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2013049693-A | Method for treating ischemic tissue | Pending | 17-Jun-2005 | ||
| US-20060292125-A1 | Using stem cell culture to treat/repair damage associated with cardiovascular event; tissue engineering; regenerative medicine | Inactive | 17-Jun-2005 | ||
| US-20060140916-A1 | Methods and compositions for treating congestive heart failure | Inactive | 22-Nov-2004 | ||
| US-20090317482-A1 | Methods and compositions for treating congestive heart failure | Inactive | 22-Nov-2004 | ||
| US-20110212068-A1 | Methods and compositions for treating congestive heart failure | Inactive | 22-Nov-2004 | A61K35/34 |
Theregen FAQs
-
When was Theregen founded?
Theregen was founded in 2003.
-
Where is Theregen headquartered?
Theregen is headquartered in San Francisco, CA.
-
What industry is Theregen in?
Theregen’s primary industry is Biotechnology.
-
Is Theregen a private or public company?
Theregen is a Private company.
-
What is Theregen’s current revenue?
The current revenue for Theregen is .
-
How much funding has Theregen raised over time?
Theregen has raised $3.27M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process